{"name":"Aviragen Therapeutics","slug":"aviragen-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":237258000,"revenueGrowth":726.7,"grossMargin":0,"rdSpend":201576000,"netIncome":16327000,"cash":186079000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-13","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: FORM 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWXIyTnhEWnl2WVRXVVBmaWZpcVZNbF91em1OT05mN1RFS2xaa3hGbEZmMnhOMmdOLUwyTDkwOEFnMWM3YWk2ZFd5VnN5d1l0M095SFdOQWFHcFdfTDZmNDBMY2R5SnpJRzNfRDlta29hanBIQ2FlRmRHMjNUZklOR1E4a3A3WlNEUG9jSU5sTWpyUW9kOTBJMDVYOTFUbUdVZjZOM3VR?oc=5","date":"2026-02-19","type":"pipeline","source":"BioPharma Dive","summary":"Altesa, run by former Trump official, raises $75M for well-traveled lung drug - BioPharma Dive","headline":"Altesa, run by former Trump official, raises $75M for well-traveled lung drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOWTVpME13MXpZMmgxREZtMFJZb2QtSDNfUC1wRmRneExPVXJvUHZXX2ZSd1pyREZfNzVYWGgxQXBmQmEtT2JkRHpWM3dwMEg4ZnlrMUl3aVhjLW53UU9mQi14QkdYVlVDXzlzRWpTRV8zMXlXRThDWGdkQU5TRm83SmJRTkpJY3kwN3hHX0dKSkl0MzhUUzV5SlRESW44OTNZWEw4?oc=5","date":"2022-06-15","type":"deal","source":"The Business Journals","summary":"RTP startup's new CEO has experienced billion-dollar deals - The Business Journals","headline":"RTP startup's new CEO has experienced billion-dollar deals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNX1AxdWtlQ2ZRdkVodGxQUkdINDlHV2kzUGdTdExsWHpXb0JHZ3pzS1k2RVRRbkJrc3ZzSGNPV2lmSlpma2R3TWhLMzVubGxLQmtPR2pOS29LakstUVdjUFU3cTN3aDBGRGdUQnVsR1Y1Nm9vMTBld21KZXhwSnNHRy1QOA?oc=5","date":"2021-07-08","type":"deal","source":"Pharmaceutical Technology","summary":"Vaxart and Altesa enter licencing deal for antiviral drug Vapendavir - Pharmaceutical Technology","headline":"Vaxart and Altesa enter licencing deal for antiviral drug Vapendavir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPcUVEQ0lRajJQY1V4dmhQSXlMa2IxcmtFWlY5TkFJaDRncjdDcE9kSk9tSWdvRjVmOVlqVVFkTzRvX0xPa0lOVXJxcmRCM29wMkRvdUxCMEVyYVpVNzVNcmVBWUUxOV9wcHY1RFh4NzZfdE43Y2dtUGVILWtYVXoyNVluQ2JBV0Qzb0hZVmdNd3IzVmQ4U3pZQzdsWGFBSGJabGpZ?oc=5","date":"2018-02-27","type":"pipeline","source":"Fierce Pharma","summary":"Prokarium raises $10M for development of thermostable oral vaccines - Fierce Pharma","headline":"Prokarium raises $10M for development of thermostable oral vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNUmE2azFpY1hMbm41WVQ1WU5PZDZDemxpMENnZUNXeGlubDgxb1VkWE1rd190RlJYM1ljX3hDZllUNTVDdUh0Y1pvUnFPUjJvSmMweVdpOVA1bldnSzNCWktrRTkxWjM1V3F6SzRXWTFOcl9uaTMwMC10MjlZX1I0WVhSdmt0UnRSU3dvQktWbGNkLWthRkJaYkZMdHMwZlNQNDBueDFTd25XaWx2RHNQakg5YV9wV3M?oc=5","date":"2017-10-31","type":"pipeline","source":"Fierce Pharma","summary":"Aviragen, Vaxart merge to develop oral vaccines for influenza, norovirus and RSV - Fierce Pharma","headline":"Aviragen, Vaxart merge to develop oral vaccines for influenza, norovirus and RSV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPTWd3THRleXAwRnYydjZwaTU3OEZyTjJ5TmJ2SUtjTV85Tk5Ubzd5UVVEcVV1ZXl1MWtoTWlNNnp5VlZyRGdZOVIwTE1TeXVuVVBPXzlJV1pmMG1ORF8yc3JRWWluRWZaSXFlN2t6emE0UXpPUy1NSnpuTzJKTkxZNkF4Zzl6QlhNTHkzejYzVmlCZXV5WkxteWFhZ2k4M25TaFgxSE0zc19fSFNKUlliOElUbm5helREcllRclNoMmRBYWh1N3kxMzdTNUxPWjVFUXFDOVdkOWp5dw?oc=5","date":"2016-04-12","type":"pipeline","source":"Reuters","summary":"Biota Pharma says changed its name to Aviragen Therapeutics - Reuters","headline":"Biota Pharma says changed its name to Aviragen Therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":237258000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":237258000,"period":"2025-12-31"},{"value":28700000,"period":"2024-12-31"},{"value":28700000,"period":"2024-12-31"},{"value":7379000,"period":"2023-12-31"},{"value":4159000,"period":"2018-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":201576000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":16327000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":186079000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}